Karaca Karadoğan, E. Et Al. 2023. Enantioseperation of 2-(1H-imidazol-1-yl)-1-(naphthalen-2-yl)ethan-1-ol which is active metabolite of anticonvulsant nafimidone. Anatolian Journal of Pharmaceutical Sciences , vol.2, no.1 , 85-95.

Karaca Karadoğan, E., ÖZDEMİR, Z., ZENNİ, Y. N., & KARAKURT, A., (2023). Enantioseperation of 2-(1H-imidazol-1-yl)-1-(naphthalen-2-yl)ethan-1-ol which is active metabolite of anticonvulsant nafimidone. Anatolian Journal of Pharmaceutical Sciences , vol.2, no.1, 85-95.

Karaca Karadoğan, Esma Et Al. "Enantioseperation of 2-(1H-imidazol-1-yl)-1-(naphthalen-2-yl)ethan-1-ol which is active metabolite of anticonvulsant nafimidone," Anatolian Journal of Pharmaceutical Sciences , vol.2, no.1, 85-95, 2023

Karaca Karadoğan, Esma K. Et Al. "Enantioseperation of 2-(1H-imidazol-1-yl)-1-(naphthalen-2-yl)ethan-1-ol which is active metabolite of anticonvulsant nafimidone." Anatolian Journal of Pharmaceutical Sciences , vol.2, no.1, pp.85-95, 2023

Karaca Karadoğan, E. Et Al. (2023) . "Enantioseperation of 2-(1H-imidazol-1-yl)-1-(naphthalen-2-yl)ethan-1-ol which is active metabolite of anticonvulsant nafimidone." Anatolian Journal of Pharmaceutical Sciences , vol.2, no.1, pp.85-95.

@article{article, author={Esma Karaca Karadoğan Et Al. }, title={Enantioseperation of 2-(1H-imidazol-1-yl)-1-(naphthalen-2-yl)ethan-1-ol which is active metabolite of anticonvulsant nafimidone}, journal={Anatolian Journal of Pharmaceutical Sciences}, year=2023, pages={85-95} }